Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

SARASOTA, Fla.--(BUSINESS WIRE)--AW Properties Global Announces October 16 UCC Sales of Membership Interests in LLCs Owning NC Cinema, NM Industrial Property and Bridgehampton Estate...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  14-September-2026 Issue: Paragon Bank plc Series 2026-1 XS3432918335 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-July-2026 Date To: 21-September-2026 Record Date: 18-September-2026 Value Date: 21-September-2026 Benchmark Rate: 3.74351% Margin: 0.5% Total Rate: 4.24351% Floor: 0% Number of Days: 68 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Total Amount...

CULVER CITY, Calif.--(BUSINESS WIRE)--This evening at the 78th Primetime Emmy Awards, Apple TV shatters records to become the most awarded network of the year, landing 29 wins overall, including Outstanding Comedy Series for Widow’s Bay as the breakout sensation sweeps all major categories with 14 wins in total and cements itself as the most Emmy-awarded freshman comedy series in history. Additionally, Widow’s Bay lands the most wins for a comedy series in a single season, as well as the most p...

NEW YORK--(BUSINESS WIRE)--Powerful Medical, a leader in AI-driven cardiovascular diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Queen of Hearts (ACS AI ECG Model). The AI-powered model is designed to identify ECG findings suggestive of urgent acute coronary syndrome (ACS), which can include ST-segment elevation myocardial infarction (STEMI) and STEMI equivalents, and urgently notify clinicians of suspected cases. Heart attack...

LONDON--(BUSINESS WIRE)--    DMO-TAS041/3728/002         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A122\26 15 September 2026   PRESS NOTICE   RESULT OF THE SALE BY TENDER OF UP TO £1250 MILLION OF 0½% TREASURY GILT 2029The United Kingdom Debt Management Office ("DMO") announces that the tender of up to £1,250 million of 0½% Treasury Gilt 2029 (ISIN Code: GB00BLPK7227) has been allocated as follows:(Note: all prices in this notice ar...

HAMBURG, Deutschland--(BUSINESS WIRE)--Marken und Agenturen buchen ChatGPT Ads ab sofort über Adform und messen sie gemeinsam mit ihren übrigen Kampagnen...

SEOUL, South Korea--(BUSINESS WIRE)--Genexine, Inc. (KOSDAQ: 095700) announced that Jaehyun Choi, Ph.D., CEO and Head of R&D, presented new preclinical data for GX-BP1, the company’s SOX2-targeting bioPROTAC, at the 2026 World Conference on Lung Cancer (WCLC) in Seoul on September 13. The mini oral presentation, titled ‘Lung-Targeted mRNA-LNP Delivery of SOX2 bioPROTAC: A Comprehensive Strategy for LUAD, LUSC, and SCLC in Monotherapy and Combination Settings’ highlighted the potential of GX...